跳至主要内容
临床试验/DRKS00007817
DRKS00007817进行中(未招募)未知

Probiotic supplementation in patients with chronic liver disease, resulting from the hepatitis C virus - ProbioC

allemand Health Solutions, Institute Rosell Inc.0 个研究点目标入组 12 人开始时间: 2015年2月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with the chronic hepatitis C virus infection and depression

排除标准

  • - Severe hepatic encephalopathy (i.e. CCF score <35 Hz)
  • -Women who are pregnant or breastfeeding
  • -Immunocompromised patients (as assessed by noting those taking immunosuppressive treatment or those with a known HIV infection)
  • -Receiving depression-focused psychotherapy less than eight weeks of screening
  • -Another diagnosis of mental illness
  • -At risk of / or actively suicidal (assessed with BDI-II and by a pyschiatrist if needed)
  • -Interferon therapy
  • -Cirrhosis (ie, Fibroscan score > 16)
  • -Intake of pre or probiotic products within previous four weeks
  • -Participation in a clinical trial with investigational drug/device during past month before enrolment

研究者

发起方
allemand Health Solutions, Institute Rosell Inc.

相似试验

Probiotic supplementation in patients with chronic... | 临床试验